Harbor Advisory Corp’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Harbor Advisory Corp’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-29,384	Closed	-$2.38M	–	86
2025 Q1	$2.38M	Sell	29,384 -721	-2%	-$64.4K	0.8%	37
2024 Q4	$2.71M	Sell	30,105 -1,420	-5%	-$138K	0.89%	37
2024 Q3	$3.11M	Sell	31,525 -145	-0.5%	-$14.2K	1.02%	35
2024 Q2	$2.94M	Sell	31,670 -1,770	-5%	-$159K	1.01%	34
2024 Q1	$3.17M	Sell	33,440 -75	-0.2%	-$6.96K	1.08%	34
2023 Q4	$2.99M	Sell	33,515 -1,700	-5%	-$126K	1.07%	34
2023 Q3	$2.57M	Buy	35,215 +25	+0.1%	+$2K	0.93%	40
2023 Q2	$2.93M	Buy	35,190 +632	+2%	+$52.9K	1.03%	37
2023 Q1	$2.63M	Sell	34,558 -100	-0.3%	-$8.3K	1.01%	35
2022 Q4	$2.88M	Buy	34,658 +229	+0.7%	+$18.5K	1.18%	35
2022 Q3	$2.73M	Buy	34,429 +1,218	+4%	+$103K	1.26%	33
2022 Q2	$2.47M	Buy	33,211 +18,302	+123%	+$1.37M	1.08%	35
2022 Q1	$1.34M	Buy	14,909 +496	+3%	+$45.8K	0.54%	48
2021 Q4	$1.61M	Sell	14,413 -3,288	-19%	-$397K	0.65%	42
2021 Q3	$2.23M	Buy	17,701 +11,986	+210%	+$1.54M	0.97%	36
2021 Q2	$774K	Buy	+5,715	New	+$751K	0.35%	52

Other funds holding XBI

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Broadwater Capital Boston, Massachusetts $134M AUM 21.11% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Harbor Advisory Corp's XBI Position: Q2 2025 in Review

Harbor Advisory Corp sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2025, closing a stake of 29,384 shares — an estimated $2.38M sold.

Harbor Advisory Corp first reported a position in XBI in Q2 2021 and held it in 16 quarters. The position peaked at $3.17M in Q1 2024. 625 funds tracked by Wall St. Rank hold XBI as of Q2 2025.

Harbor Advisory Corp reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2025 after selling out during the quarter.
Harbor Advisory Corp sold 29,384 State Street SPDR S&P Biotech ETF shares in Q2 2025, an estimated $2.38M.
Harbor Advisory Corp first reported a position in State Street SPDR S&P Biotech ETF in Q2 2021 and held it in 16 quarters.
Harbor Advisory Corp's State Street SPDR S&P Biotech ETF position peaked at $3.17M in Q1 2024.
625 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2025.

Based on Harbor Advisory Corp's 13F filing for Q2 2025, filed 12 Aug 2025.